Development of selective probes to highlight cellular organelles of human cell and tissue samples in X-ray fluorescence imaging
开发选择性探针以在 X 射线荧光成像中突出显示人体细胞和组织样本的细胞器
基本信息
- 批准号:518777768
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:WBP Position
- 财政年份:
- 资助国家:德国
- 起止时间:
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
In the arena of medicinal research, X-ray fluorescence imaging (XRFI) is emerging as a powerful analytical technique that allows for the simultaneous detection of virtually all elements heavier than aluminium in a wide range of samples including human cells and tissue sections. After a series of technological advances over the past decades, modern XRFI now offers sufficient resolving power to generate 2D and 3D elemental distribution maps from biological samples, providing researchers with the ability to localise and quantify virtually all medicinally relevant metals and non-metals with sub-cellular precision in a single analysis step. Unfortunately, these unprecedented opportunities offered by XRFI are thus far undermined by a severe lack of available probes to highlight relevant biological structures (e.g., mitochondria, lysosomes). Consequently, researchers are currently forced to subject their biological samples to additional deleterious analysis steps that are time consuming and prone to generating undesired artefacts, which ultimately limits the reliability of collected data and slows down research progress.To address these pitfalls and to render XRFI more useful for medicinal research and drug development purposes, I herewith propose the development of a set of urgently required, facile-to-use XRFI probes that will enable researchers to directly interpret generated XRFI data. These novel XRFI probes will be constructed with a fluorescent, XRFI-active, bio-orthogonal transition metal complex featuring an inert iridium-, ruthenium-, or rhenium core. The fluorescent reporter unit will be connected via a robust linker to a recognition-based targeting moiety that directs the probe’s localisation towards a selected cellular organelle.This modular design will enable a versatile mix-and-match synthetic approach to generate an array of probes with different dual-modal reporter units and targeting moieties, respectively, that can be traced by both XRFI and conventional fluorescence live-cell imaging. This strategy will facilitate the validation and optimization of the generated XRFI probes as well as provide end-users with a range of usable probes to suit the respective confines of their individual projects.With my diverse background in supramolecular- and medicinal chemistry, ranging from the development of fluorescent probes and chemosensors to the design, synthesis, and biological evaluation of new, organelle-targeted potential chemotherapeutics, I consider myself the ideal candidate for the development of these urgently required probes. Additionally, the Metzler-Nolte group at the Ruhr-University Bochum is the perfect, complementary host institution to facilitate the successful completion of this impactful research project due to their extensive knowledge base on the synthesis of metal complexes, wealth of available instrumentation, and valuable access to external synchrotron facilities to validate the final XRFI probes.
在医学研究的竞技场中,X射线荧光成像(XRFI)正在成为一种强大的分析技术,可以同时检测包括人体细胞和组织切片在内的各种样品中几乎所有比铝重的元素。经过过去几十年的一系列技术进步,现代XRFI现在提供了足够的分辨率,可以从生物样品中生成2D和3D元素分布图,使研究人员能够在一个分析步骤中以亚细胞精度定位和量化几乎所有与医学相关的金属和非金属。不幸的是,XRFI提供的这些前所未有的机会迄今为止因严重缺乏可用探针来突出相关生物结构(例如,线粒体、溶酶体)。因此,研究人员目前被迫将他们的生物样品进行额外的有害分析步骤,这些步骤耗时且容易产生不期望的伪影,这最终限制了收集数据的可靠性并减缓了研究进展。为了解决这些缺陷并使XRFI更有用于医学研究和药物开发目的,我在此提出了一套迫切需要的XRFI方法,易于使用的XRFI探头,使研究人员能够直接解释生成的XRFI数据。这些新的XRFI探针将与荧光,XRFI活性,生物正交过渡金属配合物,具有惰性铱,钌,或钌的核心。荧光报告单元将通过一个强大的连接器连接到一个基于荧光的靶向部分,该靶向部分将探针定位到选定的细胞器上。这种模块化设计将使通用的混合匹配合成方法能够分别生成具有不同双模报告单元和靶向部分的探针阵列,这些探针可以通过XRFI和常规荧光活细胞成像进行追踪。这一策略将有助于验证和优化所生成的XRFI探针,并为最终用户提供一系列可用的探针,以适应其各自项目的限制。凭借我在超分子和药物化学方面的丰富背景,从荧光探针和化学传感器的开发到新型细胞器靶向潜在化疗药物的设计,合成和生物学评价,我认为自己是开发这些迫切需要的探针的理想人选。此外,鲁尔大学波鸿的Metzler-Nolte小组是促进成功完成这一有影响力的研究项目的完美互补的主办机构,因为他们在金属络合物合成方面拥有广泛的知识基础,丰富的可用仪器,以及宝贵的外部同步加速器设施,以验证最终的XRFI探针。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Axel Steinbrueck, Ph.D.其他文献
Axel Steinbrueck, Ph.D.的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
新型M4受体选择性拮抗剂的研究
- 批准号:30973615
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Development of selective amyloid-responsive fluorescent probes
选择性淀粉样蛋白响应荧光探针的开发
- 批准号:
10467922 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Development of Small Molecule Probes for the Selective Modification and Labeling of the Mycobacterial Cell Wall
开发用于选择性修饰和标记分枝杆菌细胞壁的小分子探针
- 批准号:
10394129 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance
开发有效的、选择性的、非骨髓毒性的 FLT3 抑制剂,保留对抗常见耐药机制的功效
- 批准号:
10531587 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of Ryanodine Receptor 2 Selective Probes
Ryanodine 受体 2 选择性探针的开发
- 批准号:
10224640 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance
开发有效的、选择性的、非骨髓毒性的 FLT3 抑制剂,保留对抗常见耐药机制的功效
- 批准号:
10314075 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of Ryanodine Receptor 2 Selective Probes
Ryanodine 受体 2 选择性探针的开发
- 批准号:
9911333 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of PARP-Isoform Selective Inhibitory Chemical Probes
PARP-异构体选择性抑制化学探针的开发
- 批准号:
10437639 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Development of PARP-Isoform Selective Inhibitory Chemical Probes
PARP-异构体选择性抑制化学探针的开发
- 批准号:
10171867 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Development of in vivo active small molecule selective inhibitors of ASK1
ASK1 体内活性小分子选择性抑制剂的开发
- 批准号:
9218535 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Development of RORbeta-selective modulators as in vivo probes
作为体内探针的 RORbeta 选择性调节剂的开发
- 批准号:
9088532 - 财政年份:2015
- 资助金额:
-- - 项目类别: